Related Experiment Video
Updated: Jun 6, 2025

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Quit Attempts and Use of Cessation Aids Among U.S. Adults Who Smoke Nondaily
Daniela S Gutiérrez-Torres1, Carolyn Reyes-Guzman2, Margaret Mayer2
1Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Introduction:
About 25% of people who currently smoke cigarettes in the U.S. smoke nondaily, and relatively little is known about their intentions or attempts to quit. Active surveillance is essential to identify services needed to support smoking cessation efforts and reduce the burden of disease.
Methods:
U.S. population-wide estimates of quit attempts and use of cessation aids among adults who smoke cigarettes were calculated using data from the September 2022 wave of the Tobacco Use Supplement to the Current Population Survey. Statistical analyses were conducted in 2024. Weighted percentages and 95% CIs are presented by sociodemographic characteristics and smoking pattern.
Results:
In 2022, nearly 6 million adults (2.59 million women, 3.36 million men) in the U.S. reported smoking nondaily an average of 13.4 days per month (95% CI=12.7, 14.1). Compared with adults who smoke daily, the proportion of past-year quit attempts was higher among people who reported smoking on some days of the month (always some days: 41.8%; formerly daily: 58.4%; daily: 32.2%). However, those who smoke some days were less likely to report receiving medical advice to quit (always some days: 49.5%; formerly daily: 58.1%; daily: 72.7%), using pharmacotherapy such as nicotine replacement therapy or a prescribed medication (always some days: 17.9%; formerly daily: 32.4%; daily: 38.7%), or receiving counseling to quit smoking (always some days: 5.8%; formerly daily: 6.9%; daily: 12.0%).
Conclusions:
Given the substantial number of adults who smoke nondaily in the U.S. and their interest in quitting, developing targeted interventions and communication is an important public health priority.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...